165 related articles for article (PubMed ID: 30062974)
1. Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report.
Shukkoor AA; Thangavelu S; George NE; Priya S
Curr Drug Saf; 2019; 14(1):37-39. PubMed ID: 30062974
[TBL] [Abstract][Full Text] [Related]
2. A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
Hoogeveen RM; van der Bom T; de Boer HH; Thurlings RM; Wind BS; de Vries HJ; van Lent AU; Beuers U; van der Wal AC; Nellen FJ
Neth J Med; 2016 Feb; 74(2):89-92. PubMed ID: 26951355
[TBL] [Abstract][Full Text] [Related]
3. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
Sheen YS; Chu CY; Wang SH; Tsai TF
J Dermatolog Treat; 2009; 20(6):340-3. PubMed ID: 19954390
[TBL] [Abstract][Full Text] [Related]
4. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
[TBL] [Abstract][Full Text] [Related]
5. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Craig J; MacRae C; Melvin RG; Boggild AK
Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
[TBL] [Abstract][Full Text] [Related]
6. Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
Itha S; Kumar A; Dhingra S; Choudhuri G
BMC Gastroenterol; 2003 Aug; 3():21. PubMed ID: 12911838
[TBL] [Abstract][Full Text] [Related]
7. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy.
Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT
Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479
[TBL] [Abstract][Full Text] [Related]
8. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
[TBL] [Abstract][Full Text] [Related]
9. Dapsone hypersensitivity syndrome among leprosy patients in China.
Tian W; Shen J; Zhou M; Yan L; Zhang G
Lepr Rev; 2012 Dec; 83(4):370-7. PubMed ID: 23614255
[TBL] [Abstract][Full Text] [Related]
10. Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
Krismawati H; Irwanto A; Pongtiku A; Irwan ID; Maladan Y; Sitanggang YA; Wahyuni T; Tanjung R; Sun Y; Liu H; Zhang F; Oktavian A; Liu J
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008746. PubMed ID: 33064728
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Liu H; Wang Z; Bao F; Wang C; Sun L; Zhang H; Yu G; Mi Z; Li J; Li L; Zhao Q; Yue Z; Zhao W; Yu W; Cao J; Xiong F; Wang Y; Chai Z; Cheng X; Zhang Y; Fu F; Lang X; Wang X; Irwanto A; Krismawati H; Fu X; Sun Y; You J; Liu J; Pan Q; Chu T; Liu D; Chen S; Shen J; Yan L; Zhang G; Liu J; Zhang F; ; Xiong L; Yang J; Li J; Ke W; Li M; Ning Y; Xiong J; Li M; Xiong M; Yang B; Duan Q; Wang H; Li W; Kuang Y; Li J; Wang L; Cao Q; Xiao P; Xiao B; Zhang L; Lin Z; Wang Y; Shen Y; Yan L; Wu W; Zheng H; Zhan X; Li W; Shang X; Xu Y; Liu Q
JAMA Dermatol; 2019 Jun; 155(6):666-672. PubMed ID: 30916737
[TBL] [Abstract][Full Text] [Related]
12. Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus.
Pai S; Munshi R; Nayak C
Indian J Pharmacol; 2017; 49(5):396-398. PubMed ID: 29515281
[TBL] [Abstract][Full Text] [Related]
13. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
[TBL] [Abstract][Full Text] [Related]
14. A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.
Wang N; Parimi L; Liu H; Zhang F
Am J Trop Med Hyg; 2017 May; 96(5):1014-1018. PubMed ID: 28167593
[TBL] [Abstract][Full Text] [Related]
15. Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal.
Rao PN; Lakshmi TS
Lepr Rev; 2001 Mar; 72(1):57-62. PubMed ID: 11355519
[TBL] [Abstract][Full Text] [Related]
16. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E.
Chogle A; Nagral A; Soni A; Agale S; Jamadar Z
Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824
[TBL] [Abstract][Full Text] [Related]
17. Lack of Suspicion of Dapsone Hypersensitivity Syndrome in a Leprosy Patient: Case Report with Fatal Outcome.
Ansah R; Arkoh EA; Quao BO; Groger M
Res Rep Trop Med; 2023; 14():135-139. PubMed ID: 38170098
[TBL] [Abstract][Full Text] [Related]
18. Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome.
Zhu KJ; He FT; Jin N; Lou JX; Cheng H
J Clin Pharm Ther; 2009 Aug; 34(4):489-92. PubMed ID: 19583683
[TBL] [Abstract][Full Text] [Related]
19. Th17 Response of Borderline-Lepromatous Leprosy Inhibits Rash Manifestation of Dapsone Hypersensitivity Syndrome: Case Report.
de Nardo Vanzela T; Bernardes Filho F; Wambier CG; Faria FM; Foss NT; Frade MAC
Am J Dermatopathol; 2018 Mar; 40(3):205-208. PubMed ID: 28937434
[TBL] [Abstract][Full Text] [Related]
20. Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol.
Krismawati H; Ferdiana A; Irwanto A; Budiawan T; Imaniar C; Wahyuni T; Singh P; Mieras L; Pongtiku A
BMJ Open; 2022 May; 12(5):e057173. PubMed ID: 35545382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
